NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics

News   May 13, 2008

 
NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
 
 
 

RELATED ARTICLES

Protein Essential for Making Stem Cells Identified

News

The discovery by Stanford scientists drills a peephole into the black box of cellular reprogramming and may lead to new ways to generate induced pluripotent stem cells in the laboratory.

READ MORE

Novel ALS Therapy in Human Clinical Trials

News

A phase one/two clinical trial has launched to investigate whether a drug could benefit people with ALS whose disease is caused by mutations in a gene called SOD1

READ MORE

3D Super-Resolution Nanoscopes Used To Identify Amyloid Plaques

News

A new development in 3D super-resolution imaging gives insight on Alzheimer's disease

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy